IRIS
VOGRIG, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.465
AS - Asia 3.357
EU - Europa 1.414
SA - Sud America 626
Continente sconosciuto - Info sul continente non disponibili 418
AF - Africa 95
OC - Oceania 3
Totale 9.378
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.313
SG - Singapore 1.778
CN - Cina 547
IT - Italia 534
BR - Brasile 493
HK - Hong Kong 311
VN - Vietnam 268
FR - Francia 144
DE - Germania 141
RU - Federazione Russa 136
FI - Finlandia 91
IN - India 84
KR - Corea 76
CA - Canada 72
IE - Irlanda 72
BD - Bangladesh 68
GB - Regno Unito 61
AR - Argentina 60
NL - Olanda 49
JP - Giappone 37
MX - Messico 35
UA - Ucraina 31
AT - Austria 29
ID - Indonesia 28
ES - Italia 27
TR - Turchia 24
EC - Ecuador 23
TG - Togo 23
IQ - Iraq 21
SE - Svezia 20
ZA - Sudafrica 18
PK - Pakistan 17
SA - Arabia Saudita 14
CO - Colombia 13
PL - Polonia 13
JM - Giamaica 12
MA - Marocco 11
VE - Venezuela 10
KZ - Kazakistan 9
TN - Tunisia 9
TW - Taiwan 9
CL - Cile 8
PE - Perù 8
PT - Portogallo 8
BE - Belgio 7
CZ - Repubblica Ceca 7
EG - Egitto 7
LT - Lituania 7
NP - Nepal 7
DZ - Algeria 6
PY - Paraguay 6
AZ - Azerbaigian 5
CH - Svizzera 5
CR - Costa Rica 5
KE - Kenya 5
KG - Kirghizistan 5
MY - Malesia 5
OM - Oman 5
TH - Thailandia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
HU - Ungheria 4
PH - Filippine 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
JO - Giordania 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
NI - Nicaragua 3
RO - Romania 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
CU - Cuba 2
GD - Grenada 2
HT - Haiti 2
MD - Moldavia 2
PS - Palestinian Territory 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
Totale 8.942
Salva come PNG Salva come JPEG
Città #
Singapore 594
Ashburn 395
Council Bluffs 360
Hong Kong 306
Beijing 237
San Jose 203
Boardman 167
Fairfield 136
Lauterbourg 101
Los Angeles 100
Ho Chi Minh City 86
Seoul 76
Chandler 75
Trieste 75
Hefei 74
Dallas 73
Dublin 72
Helsinki 71
Houston 63
New York 63
Woodbridge 63
Seattle 61
Santa Clara 58
Milan 57
Redondo Beach 54
Hanoi 49
Munich 49
São Paulo 47
Wilmington 46
Cambridge 41
Buffalo 35
Ogden 29
Frankfurt am Main 27
Nuremberg 27
Belluno 25
Chicago 25
Phoenix 25
Orem 24
The Dalles 24
Venezia 24
Dearborn 23
Lomé 23
Rome 23
Tokyo 22
Princeton 20
Ann Arbor 19
Hyderabad 19
Jacksonville 19
Toronto 19
Udine 19
Mexico City 18
Montreal 18
Atlanta 17
Da Nang 17
Dong Ket 17
Amsterdam 16
London 16
Tavagnacco 16
Rio de Janeiro 15
Bologna 14
Lappeenranta 14
Chennai 13
San Francisco 13
Brooklyn 12
Denver 12
Redmond 12
San Diego 12
Mumbai 11
Poplar 11
Boston 10
Belo Horizonte 9
Biên Hòa 9
Düsseldorf 9
Goiânia 9
Guarulhos 9
Haiphong 9
Norwalk 9
Vienna 9
Guayaquil 8
Izmir 8
Johannesburg 8
Kingston 8
New Delhi 8
Porto Alegre 8
Baghdad 7
Brussels 7
Manchester 7
Naples 7
Philadelphia 7
Stockholm 7
Avon 6
Charlotte 6
Guangzhou 6
Istanbul 6
Jakarta 6
Lisbon 6
Manassas 6
Miami 6
Quito 6
Riyadh 6
Totale 4.829
Salva come PNG Salva come JPEG
Nome #
Intra-carotid self-injection of alprazolam: an unusual cause of unilateral multiembolic stroke 213
Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis 168
Epidemiology of autoimmune versus infectious encephalitis 164
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 148
Epidemiology of paraneoplastic neurological syndromes: a population-based study 144
Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis 142
Effect of thymectomy on refractory autoimmune status epilepticus 140
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario 137
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review 126
Back to the future: encephalitis lethargica as an autoimmune disorder? 124
Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features 123
Seizure specificities in patients with antibody-mediated autoimmune encephalitis 122
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 118
Central nervous system adverse events of immune checkpoint inhibitors 115
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study 113
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 111
Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review 109
Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis 103
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes 103
Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA) 103
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era 103
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features 102
Sudden unexpected death in epilepsy and ictal asystole in patients with autoimmune encephalitis: a systematic review 102
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors 102
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes 97
SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques 95
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis 95
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota 94
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 93
Stroke in patients with SARS-CoV-2 infection: case series 93
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 92
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 92
Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research 92
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases 91
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 88
Central nervous system complications associated with immune checkpoint inhibitors 87
Movement disorders in oncology: From clinical features to biomarkers 86
Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination” 85
Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome 84
18F-FDG PET brain findings in disease-discordant monozygotic mosaic twins with Cri du Chat (5p-) syndrome 84
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 84
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis 83
Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohort 83
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration 82
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 81
Associations between HLA and autoimmune neurological diseases with autoantibodies 79
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis 78
Bornavirus associated with fatal human encephalitis 78
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? 77
Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study 77
Role of LGI1 protein in synaptic transmission: From physiology to pathology 77
Adenovirus COVID-19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis 77
Unclear association between COVID-19 and Guillain-Barré syndrome 77
Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations 76
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network 76
Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination 76
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors 76
Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment 76
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients 74
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis 74
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 74
A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events 74
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma 72
Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA B R Antibodies 71
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 71
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis 70
Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis 69
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 69
Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis 69
Neuroimmune disorders in COVID-19 69
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience 69
Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses 68
Paraneoplastic encephalitis: clinically based approach on diagnosis and management 68
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 68
Proceedings of the “International Congress on Structural Epilepsy & Symptomatic Seizures” (STESS, Gothenburg, Sweden, 29–31 March 2023) 67
Stroke in patients with COVID-19: Clinical and neuroimaging characteristics 67
Glioblastoma as differential diagnosis of autoimmune encephalitis 66
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors 66
Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies 66
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity 65
How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update 65
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors 65
Immune Checkpoint Inhibitor-Related Cerebellar Toxicity: Clinical Features and Comparison with Paraneoplastic Cerebellar Ataxia 65
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABABR and Anti-Hu Paraneoplastic Neurological Syndromes 65
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies 64
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis 64
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors. Focus on Chronic Toxicities 64
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes 63
Immunomodulation in the acute phase of autoimmune encephalitis 62
Nystagmus and lower extremity hyperalgesia after colectomy 62
Prognosis of status epilepticus in adults: recent advances and future directions 59
Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis 59
Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case 58
Dramatic response to delayed treatment with tocilizumab in new-onset refractory status epilepticus 56
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management 55
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis 55
Postencephalitic epilepsy in children and adults: Etiology matters 54
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma 52
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 52
Iatrogenic NORSE: Immune checkpoint inhibitor-related anti-GFAP autoimmune astrocytopathy 52
Totale 8.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022156 0 0 37 6 2 0 13 4 3 20 48 23
2022/2023528 20 18 3 19 176 179 4 8 31 6 17 47
2023/2024343 28 22 5 24 40 18 9 31 44 57 29 36
2024/20252.297 85 140 93 70 71 83 110 104 294 240 404 603
2025/20264.511 349 406 415 552 538 302 556 160 274 352 337 270
2026/2027830 246 401 183 0 0 0 0 0 0 0 0 0
Totale 9.378